Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Sentinel Oncology Limited patents

List of Sentinel Oncology Limited patents

List of Indian Institute Of Technology, Madras patents

List of FDNA Inc. patents

List of Light Age, Inc. patents

Investors in Notable Labs

List of companies in Dream Incubator's investment portfolio

Patents where

Current Assignee

Name

is

‌

Sentinel Oncology Limited

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10973817 Pharmaceutical compounds	Patent 10973817 was granted and assigned to Sentinel Oncology Limited on April, 2021 by the United States Patent and Trademark Office.	‌ Sentinel Oncology Limited	‌ Sentinel Oncology Limited		United States Patent and Trademark Office	10973817	April 13, 2021
	‌ US Patent 11208405 Pyrrole derivatives as PLK1 inhibitors	Patent 11208405 was granted and assigned to Sentinel Oncology Limited on December, 2021 by the United States Patent and Trademark Office.	‌ Sentinel Oncology Limited	‌ Sentinel Oncology Limited		United States Patent and Trademark Office	11208405	December 28, 2021
	‌ US Patent 9630931 Pharmaceutically active pyrazine derivatives	Patent 9630931 was granted and assigned to Sentinel Oncology Limited on April, 2017 by the United States Patent and Trademark Office.	‌ Sentinel Oncology Limited	‌ Sentinel Oncology Limited		United States Patent and Trademark Office	9630931	April 25, 2017
	‌ US Patent 8716287 Pharmaceutical compounds	Patent 8716287 was granted and assigned to Sentinel Oncology Limited on May, 2014 by the United States Patent and Trademark Office.		‌ Sentinel Oncology Limited		United States Patent and Trademark Office	8716287	May 6, 2014
	‌ US Patent 10344033 2-aminoquinazoline derivatives as P70S6 kinase inhibitors	Patent 10344033 was granted and assigned to Sentinel Oncology Limited on July, 2019 by the United States Patent and Trademark Office.	‌ Sentinel Oncology Limited	‌ Sentinel Oncology Limited		United States Patent and Trademark Office	10344033	July 9, 2019
	‌ US Patent 8716473 Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase	Patent 8716473 was granted and assigned to Sentinel Oncology Limited on May, 2014 by the United States Patent and Trademark Office.		‌ Sentinel Oncology Limited		United States Patent and Trademark Office	8716473	May 6, 2014
	‌ US Patent 10730882 2-aminoquinazoline derivatives as P70S6 kinase inhibitors		‌ Sentinel Oncology Limited	‌ Sentinel Oncology Limited		United States Patent and Trademark Office	10730882	August 4, 2020
	‌ US Patent 10144726 Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer	Patent 10144726 was granted and assigned to Sentinel Oncology Limited on December, 2018 by the United States Patent and Trademark Office.	‌ Sentinel Oncology Limited	‌ Sentinel Oncology Limited		United States Patent and Trademark Office	10144726	December 4, 2018
	‌ US Patent 11884656 Pyrrole derivatives as PLK1 inhibitors	Patent 11884656 was granted and assigned to Sentinel Oncology Limited on January, 2024 by the United States Patent and Trademark Office.	‌ Sentinel Oncology Limited	‌ Sentinel Oncology Limited		United States Patent and Trademark Office	11884656	January 30, 2024
	‌ US Patent 11786524 Pharmaceutical compounds	Patent 11786524 was granted and assigned to Sentinel Oncology Limited on October, 2023 by the United States Patent and Trademark Office.	‌ Sentinel Oncology Limited	‌ Sentinel Oncology Limited		United States Patent and Trademark Office	11786524	October 17, 2023

10 results

0 selected

10 results

0 selected